BlackRock’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Sell |
|
|||||
|
2025
Q1 | $76.2M | Sell |
|
|||||
|
2024
Q4 | $70.7M | Sell |
|
|||||
|
2024
Q3 | $95.4M | Sell |
|
|||||
|
2024
Q2 | $85.7M | Buy |
|
|||||
|
2024
Q1 | $82.7M | Buy |
|
|||||
|
2023
Q4 | $55.8M | Buy |
|
|||||
|
2023
Q3 | $54.2M | Sell |
|
|||||
|
2023
Q2 | $44.5M | Sell |
|
|||||
|
2023
Q1 | $36.4M | Sell |
|
|||||
|
2022
Q4 | $53.7M | Sell |
|
|||||
|
2022
Q3 | $46.6M | Buy |
|
|||||
|
2022
Q2 | $34.3M | Buy |
|
|||||
|
2022
Q1 | $34.7M | Buy |
|
|||||
|
2021
Q4 | $41M | Buy |
|
|||||
|
2021
Q3 | $35.5M | Buy |
|
|||||
|
2021
Q2 | $34.8M | Buy |
|
|||||
|
2021
Q1 | $41.7M | Buy |
|
|||||
|
2020
Q4 | $38.7M | Buy |
|
|||||
|
2020
Q3 | $28M | Buy |
|
|||||
|
2020
Q2 | $30.5M | Buy |
|
|||||
|
2020
Q1 | $14.4M | Sell |
|
|||||
|
2019
Q4 | $10.5M | Sell |
|
|||||
|
2019
Q3 | $9.51M | Buy |
|
|||||
|
2019
Q2 | $15M | Buy |
|
|||||
|
2019
Q1 | $17.5M | Buy |
|
|||||
|
2018
Q4 | $18.1M | Buy |
|
|||||
|
2018
Q3 | $11.5M | Buy |
|
|||||
|
2018
Q2 | $173K | Buy |
|